Azacitidine IV/SC Injection

Azacitidine IV/SC Injection 100 mg/vial Introduction

Azacitidine IV/SC Injection 100 mg/vial is an antimetabolite chemotherapy drug used for the treatment of hematopoietic neoplasms. It is a type of pyrimidine analog generally employed for its inhibitory effects on DNA methyltransferase, which plays a crucial role in the regulation of gene expression

Uses for Azacitidine IV/SC Injection 100 mg/vial

Azacitidine IV/SC Injection 100 mg/vial is used to treat cancer of the bone marrow, including acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia. It may also be used to treat other conditions such as myeloproliferative neoplasms and lymphomas.

Brand Name	Azacitidine
Type	IV/SC Injection
Weight	100 mg/vial
Generic	Azacitidine
Manufacturer	ZAS Corporation
Available in	English বাংলা

Mechanism of Action

Azacitidine IV/SC Injection 100 mg/vial works by blocking the synthesis of nucleic acid, thereby impeding the growth and spread of cancer cells. It works by inhibiting the components which are necessary for nucleic acid synthesis, and as a result, the cancer cells are unable to replicate. It has also been observed to cause epigenetic changes in the cancer cells, thus affecting their survival.

How Long Does It Take to Work?

Azacitidine IV/SC Injection 100 mg/vial may take up to several weeks to work, although some patients may respond quicker depending on their condition. It is typically given in a series of intravenous infusions over the course of 4 to 8 weeks, which can cause some patients to start to feel the effects of the drug within that period.

Absorption, Route of Elimination, Dosage

Azacitidine IV/SC Injection 100 mg/vial is administered intravenously. It is rapidly and widely distributed throughout the body and is metabolized in the liver. The drug has an elimination half-life of 2 to 9 hours. The usual dose is 75 mg/m2 given once a day for 7 days every 14 days.

Administration

Azacitidine IV/SC Injection 100 mg/vial is usually given intravenously (through an IV) in a hospital or clinic setting over a period of several weeks. It can also be administered subcutaneously (under the skin) in some cases. It is sometimes combined with other chemotherapy drugs.

Side Effects

Common side effects of Azacitidine IV/SC Injection 100 mg/vial include nausea, vomiting, diarrhea, constipation, loss of appetite, fatigue, dizziness, headache, rash, and low blood cell counts. More serious side effects include serious neurologic reactions, infections, and anemia.

Toxicity

The toxicity associated with Azacitidine IV/SC Injection 100 mg/vial can be severe, particularly in cases where patients are receiving high doses. Symptoms of overdose can include confusion, arrhythmias, seizures, severe hypotension, and coma. Patients should be closely monitored for signs of toxicity during treatment.

Precautions

Patients should be monitored for signs and symptoms of toxicity, especially with prolonged use or high doses of Azacitidine IV/SC Injection 100 mg/vial. Women who are pregnant should inform their healthcare provider before using this drug. The use of Azacitidine IV/SC Injection 100 mg/vial in patients with renal or hepatic impairment is not recommended.

Interactions

Azacitidine IV/SC Injection 100 mg/vial may interact with other medications, including anticoagulants, diuretics, anti-cancer medications, and corticosteroids. Patients should inform their healthcare provider of all medications they are taking before starting treatment with Azacitidine IV/SC Injection 100 mg/vial.

Disease Interaction

Azacitidine IV/SC Injection 100 mg/vial may not be suitable for patients with certain pre-existing medical conditions. It should not be used in patients with severe renal or hepatic impairment, or in those with severe bone marrow suppression. Caution should be exercised in patients with diabetes, cardiac and pulmonary disease, and other diseases which may affect blood cell counts.

Drug Interactions

Azacitidine IV/SC Injection 100 mg/vial may interact with certain medications, including anticoagulants, diuretics, anti-cancer medications, and corticosteroids. Patients should inform their healthcare provider of all medications they are taking before starting treatment with Azacitidine IV/SC Injection 100 mg/vial.

Food Interactions

Azacitidine IV/SC Injection 100 mg/vial has no known food interactions, but may interact with certain foods when taken in large quantities. It is important to follow the dosage instructions on the package and to avoid taking large amounts of alcohol or caffeine while on Azacitidine IV/SC Injection 100 mg/vial.

Pregnancy Use

Azacitidine IV/SC Injection 100 mg/vial should not be used during pregnancy, as it may cause harm to the developing fetus. Women who are pregnant or trying to conceive should inform their healthcare provider before using this drug.

Lactation Use

There is insufficient information on the use of Azacitidine IV/SC Injection 100 mg/vial during lactation. Breastfeeding while taking this drug is not recommended.

Acute Overdose

An overdose of Azacitidine IV/SC Injection 100 mg/vial can be life-threatening. Symptoms of overdose can include confusion, arrhythmias, seizures, severe hypotension, and coma. In such cases, patients should seek immediate medical attention.

Contraindication

The use of Azacitidine IV/SC Injection 100 mg/vial is contraindicated in patients who are pregnant, breastfeeding, or have pre-existing medical conditions such as renal or hepatic impairment, severe bone marrow suppression, diabetes, cardiac and pulmonary disease, or other diseases which may affect blood cell counts.

Dosage and Use Direction

The usual dose of Azacitidine IV/SC Injection 100 mg/vial is 75 mg/m2 given once a day for 7 days every 14 days. The exact dosage and duration of treatment depends on the patient's condition and response to therapy. Patients should take this medication exactly as prescribed by their healthcare provider.

Storage Condition

Azacitidine IV/SC Injection 100 mg/vial should be stored at room temperature in an airtight container. Patients should keep this medication out of reach of children, and it should not be used beyond the expiration date.

Volume of Distribution

Azacitidine IV/SC Injection 100 mg/vial has a large volume of distribution of approximately 16 L/kg. This makes it relatively cozy for the drug to be distributed throughout the body.